Harvard Drug Research Fraud and Cover: How does the off-label use

Harvard Drug Research Fraud and Cover: How does the off-label use
Effects of drugs and money corrupts the research enterprise. It is a given.

What is the reason they are less pharmaceutical companies spend billions to find off-label uses of their products - uses that have not been cleared by the FDA in the drug submission for approval.

Use informal enables companies to get the drugs, "the back door" can never, and I mean never, with abandon by going directly to the FDA for approval of a new use of a product - what is known today as the unofficial use.

I hoped that researchers will not spoil the experimentation of new businesses or deactivate the tag, and the use of drugs to treat children consulting fees to cover the Big Pharma. But that's what happened.

More important than what happened so he came in the bottom of all this is a serious mistake that the United States did allow the operation of the informal use.

The devil is in the details, here is the story as it unfolded.

The main Harvard professors who study off-label uses, and a gold mine in the pharmaceutical industry, had violated the National Institute of Health reports requirements when you receive more than $ 10,000 a society subject, as New York Times, "the researchers were able to detect drug payment" June 8, 2008. This is not enough.

If Harvard does not release them, and they will be complicit in hiding.

Throw them off campus. Bell loud and clear that no matter how famous or excellent, if you do not play the game, you can not play at all. NIH should prohibit never for grants.

Do not throw the baby out with the bath water. Once it has provided the appropriate sanction, and give these researchers the opportunity to polish tarnished reputation. Enable them to conduct research under the supervision of the officer who knows that "Veritas", I mean the truth, accuracy and honesty and integrity, and he is more than a slogan.